Preferred Name | Glipizide | |
Synonyms |
|
|
Definitions |
A short-acting, second-generation sulfonylurea with hypoglycemic activity. Glipizide is rapidly absorbed, has a very quick onset of action and a short half-life. This agent is extensively metabolized in the liver and the metabolites as well as the unchanged form are excreted in the urine. |
|
ID |
http://purl.obolibrary.org/obo/NCIT_C29074 |
|
CAS_Registry |
29094-61-9 |
|
Chemical_Formula |
C21H27N5O4S |
|
code |
C29074 |
|
Contributing_Source |
FDA |
|
definition |
A short-acting, second-generation sulfonylurea with hypoglycemic activity. Glipizide is rapidly absorbed, has a very quick onset of action and a short half-life. This agent is extensively metabolized in the liver and the metabolites as well as the unchanged form are excreted in the urine. |
|
FDA_UNII_Code |
X7WDT95N5C |
|
in_subset | ||
label |
Glipizide |
|
Legacy Concept Name |
Glipizide |
|
NCI_Drug_Dictionary_ID |
775361 |
|
PDQ_Closed_Trial_Search_ID |
775361 |
|
PDQ_Open_Trial_Search_ID |
775361 |
|
Preferred_Name |
Glipizide |
|
prefixIRI |
NCIT:C29074 |
|
prefLabel |
Glipizide |
|
Semantic_Type |
Pharmacologic Substance |
|
UMLS_CUI |
C0017642 |
|
subClassOf |